Impact of Acute In-Hospital Postburn Pruritus on Quality of Life: A Cross-Sectional Study
Journal of Burn Care & Research · 2026
DOI: 10.1093/jbcr/iraf144 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Journal of Burn Care & Research, 2026. Verfasst von Mohammad Tolouei und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Faculty of Medicine, Guilan University of Medical Sciences, Velayat Hospital, Namjoo St, Rasht, Guilan 4193713194, Ira…. Hauptthemen laut MEDLINE: Burns, Pruritus, Quality of Life. Die Arbeit nennt 35 Literaturangaben.
Abstract (Originalsprache)
Itching following a burn injury is a frequent complication that significantly affects patients’ well-being. Despite its prevalence, the acute effects of itching during hospitalization and its correlation with specific burn characteristics remain under-researched, particularly in non-Western populations. In 2021, we carried out a cross-sectional study involving 268 adult patients who were admitted for a minimum of 48 hours after burn injury. We collected data through interviews and medical records, focusing on demographics, burn severity—categorized by total body surface area, tissue damage depth, and specific anatomical locations—and itch parameters, which were evaluated using a patient-reported intensity scale (0-10), duration, and areas affected. We utilized the ItchyQoL questionnaire to measure long-term well-being and the impact of itching on physical, emotional, and functional quality of life. Analyses included parametric and nonparametric tests as well as multivariable regression to evaluate how characteristics of itch and burn severity influenced recovery and quality of life. Itchy patients exhibited more extensive skin damage, deeper injuries, and prolonged hospitalizations compared with those without itching. Increased itch intensity and duration were linked to lower ItchyQoL scores, signifying a greater detrimental effect on quality of life. In multivariable analysis, itch intensity was identified as the most significant predictor of diminished well-being. The severity and duration of itching during hospitalization notably impact recovery and long-term quality of life. Addressing severe itching early can reduce hospital stays and promote healing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Surgery, Faculty of Medicine, Guilan University of Medical Sciences, Velayat Hospital, Namjoo St, Rasht, Guilan 4193713194, Iran.
- Burn and Regenerative Medicine Research Center, Guilan University of Medical Sciences, Velayat Hospital, Namjoo St, Rasht, Guilan 4193713194, Iran.
- Rasht College of Nursing and Midwifery, Guilan University of Medical Sciences, Velayat Hospital, Namjoo St, Rasht, Guilan 4193713194, Iran.
- Biostatistics, Social Determinants of Health Research Center (SDHRC), Guilan University of Medical Sciences, Velayat Hospital, Namjoo St, Rasht, Guilan 4193713194, Iran.
- Department of Plastic and Reconstructive Surgery, School of Medicine, Guilan University of Medical Sciences, Velayat Hospital, Namjoo St, Rasht, Guilan 4193713194, Iran.
ORCID-Profile: Mohammad Tolouei, Sanaz Masoumi, Mehrnaz Kooshanfar, Ehsan Kazemnezhad Leyli, Ramyar Farzan
Zitieren
APA
Tolouei, M., Masoumi, S., Kooshanfar, M., Kazemnezhad Leyli, E., & Farzan, R. (2026). Impact of Acute In-Hospital Postburn Pruritus on Quality of Life: A Cross-Sectional Study. Journal of Burn Care & Research. https://doi.org/10.1093/jbcr/iraf144
Vancouver
Tolouei M, Masoumi S, Kooshanfar M, Kazemnezhad Leyli E, Farzan R. Impact of Acute In-Hospital Postburn Pruritus on Quality of Life: A Cross-Sectional Study. Journal of Burn Care & Research. 2026. doi:10.1093/jbcr/iraf144
BibTeX
@article{Tolouei2026,
author = {Tolouei, Mohammad and Masoumi, Sanaz and Kooshanfar, Mehrnaz and Kazemnezhad Leyli, Ehsan and Farzan, Ramyar},
title = {Impact of Acute In-Hospital Postburn Pruritus on Quality of Life: A Cross-Sectional Study},
journal = {Journal of Burn Care & Research},
year = {2026},
doi = {10.1093/jbcr/iraf144}
}
EUVIMED